Literature DB >> 18175822

Biochemical analysis of the native TRAIL death-inducing signaling complex.

Henning Walczak1, Tobias L Haas.   

Abstract

The extrinsic apoptosis pathway is activated when certain members of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) are oligomerized by their cognate ligands that are members of the TNF superfamily (TNFSF). The apoptosis-inducing capacity of a member of the TNFRSF relies on the presence of a death domain (DD) in the intracellular portion of the receptor protein. Such receptors are also referred to as death receptors. Binding of a TNFSF ligand to a TNFRSF receptor that is expressed on the surface of a cell results in the formation of a receptor proximal protein complex. This protein complex is the platform for further signaling events within the cell. In case of death receptors like TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1/DR4), TRAIL-R2 (KILLER/APO-2/DR5/TRICK), CD95 (Fas, APO-1), or TNF receptor 1 (TNF-R1), this complex is termed death-inducing signaling complex (DISC). The compositions of the various DISCs have been intensively studied in the last 12 years. For the CD95 and the TRAIL-R1/R2 DISCs, it is now clear that the adaptor protein Fas-associated DD protein (FADD) forms part of these complexes and is necessary for recruitment of the proapoptotic signaling molecules caspase-8 and caspase-10. Recruitment of these proteases allows for their activation at the DISC and subsequent induction of apoptosis. The caspase-8 homologous cellular FLICE-like inhibitory protein (cFLIP) can also be recruited to the DISC. cFLIP acts as an anti-apoptotic regulator by interfering with activation of caspases 8 and 10 at the DISC. Interestingly, treatment of TRAIL-resistant tumor cells with conventional chemotherapeutic drugs or with proteasome inhibitors renders these cells sensitive for TRAIL-induced apoptosis. By applying the methodology of the biochemical analysis of the TRAIL DISC described here, we were able to show that this sensitization is mainly due to changes in the biochemical composition of the DISC as the apoptosis-initiating protein complex of the extrinsic pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175822     DOI: 10.1007/978-1-59745-339-4_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  28 in total

1.  Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes.

Authors:  Dirk Mühlbauer; Julia Dzieciolowski; Martin Hardt; Andreas Hocke; Kristina L Schierhorn; Ahmed Mostafa; Christin Müller; Christian Wisskirchen; Susanne Herold; Thorsten Wolff; John Ziebuhr; Stephan Pleschka
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours.

Authors:  G Itoh; S Chida; K Yanagihara; M Yashiro; N Aiba; M Tanaka
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

3.  Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway.

Authors:  Hua Qin; Xiaoyan Du; Yan Zhang; Ru Wang
Journal:  Tumour Biol       Date:  2013-09-19

4.  Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL.

Authors:  Alena Vaculova; Vitaliy Kaminskyy; Elham Jalalvand; Olga Surova; Boris Zhivotovsky
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

5.  Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.

Authors:  Chih Wen Tseng; Archana Monie; Cornelia Trimble; Ronald D Alvarez; Warner K Huh; Donald J Buchsbaum; J Michael Straughn; Mei-Cheng Wang; Hideo Yagita; Chien-Fu Hung; T-C Wu
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

6.  The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.

Authors:  Ning Zhang; Xiaolong Wang; Qiang Huo; Xiaoyan Li; Huiyun Wang; Pascal Schneider; Guohong Hu; Qifeng Yang
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

Review 7.  Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.

Authors:  Valeriya Gyurkovska; Nina Ivanovska
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

Review 8.  Following TRAIL's path in the immune system.

Authors:  Christina Falschlehner; Uta Schaefer; Henning Walczak
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

9.  DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis.

Authors:  Andreas Herbst; Constanze Bayer; Claudia Wypior; Frank T Kolligs
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

10.  Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment.

Authors:  Peter Geserick; Mike Hupe; Maryline Moulin; W Wei-Lynn Wong; Maria Feoktistova; Beate Kellert; Harald Gollnick; John Silke; Martin Leverkus
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.